Your session is about to expire
← Back to Search
Triphasic CT for Hepatitis C
N/A
Waitlist Available
Led By Christine Pocha, MD, PhD
Research Sponsored by Minneapolis Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will compare ultrasound and CT scanning for detecting early liver cancer in patients with advanced liver disease.
Eligible Conditions
- Hepatitis C
- Liver Disease
- Liver Cirrhosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy of screening measure to detect very early/early stage HCC (Barcelona Clinic Liver Cancer Staging System)
Secondary outcome measures
Cost - Effectiveness of screening measure
Trial Design
2Treatment groups
Active Control
Group I: Triphasic CTActive Control1 Intervention
Triphasic CT of the abdomen with and without contrast every 12 months with alpha-fetoprotein every 6 months.
Group II: UltrasoundActive Control1 Intervention
Ultrasound of the upper left quadrant with alpha-fetoprotein testing every 6 months.
Find a Location
Who is running the clinical trial?
Minneapolis Veterans Affairs Medical CenterLead Sponsor
72 Previous Clinical Trials
14,620 Total Patients Enrolled
1 Trials studying Hepatitis C
64 Patients Enrolled for Hepatitis C
Christine Pocha, MD, PhDPrincipal InvestigatorMinneapolis Veterans Affairs Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger